January 2005
Investment Dealers' Digest;1/31/2005, Vol. 71 Issue 4, p17
Trade Publication
The article focuses on the performance of Initial Public Offerings for the last 360 days. Offer price for New River Pharmaceuticals Inc. is 8.00 and price on January 26, 2005 was 21.07 with percent change of 163.375. W Hambrecht is the book manager. Offer price for Xcyte Therapies Inc. is 8.00 and price on January 26, 2005 was 2.39 with percent change of -70.125. Piper Jaffray is the book manager of the firm. Offer price for Corcept Therapeutics Inc. is 12.00 and price on January 26, 2005 was 5.08 with percent change of -57.667 and Thomas Weisel is the book manager.


Related Articles

  • AFTERMARKET PERFORMANCE.  // Investment Dealers' Digest;1/17/2005, Vol. 71 Issue 2, p21 

    The article presents information on performance of initial public offerings made by business enterprises in 2004. Information has been presented in tabular form. Information on offer price, offer, date, amount of finance, etc. has been provided. Some of the business enterprises that have been...

  • Financings Roundup.  // BioWorld Today;6/28/2010, Vol. 21 Issue 123, p2 

    This section offers news briefs on corporate financings including the pricing by Corcept Therapeutics Inc. of an underwritten public offering of common stock, agreements signed by Neuralstem Inc. to sell 10 million U.S. dollars of units, and a plan by Palatin Technologies Inc. to raise two...

  • Aftermarket Performance.  // Investment Dealers' Digest;11/1/2004, Vol. 70 Issue 42, p19 

    The article presents information on IPO performances in U.S.-based business enterprises. Jed Oil has an offer price of 5.50, 51Job.lnc. has an offer price of 14.00, Google has an offer price of 85.00 and Marchex has an offer price of 6.50. Some other companies such as Stoktek Holdings, Xcyte...

  • AFTERMARKET PERFORMANCE.  // Investment Dealers' Digest;12/13/2004, Vol. 70 Issue 48, p24 

    The article discusses aftermarket performance of the initial public offerings (IPO) of various business enterprises in 2004. Companies that performed well include Cogent, Volterra Semiconductor and Interchange. Xcyte Therapies Inc., Staktek Holdings Inc. and Saystar Technologies are some...

  • Aftermarket Performance.  // Investment Dealers' Digest;11/22/2004, Vol. 70 Issue 45, p17 

    Presents data on the initial public offering (IPO) deals in the aftermarket sector, for 2004. Shanda Interactive Enterprise; Volterra Semiconductor; RightNow Technologies; Syneron Medical; Staktek Holdings; Xcyte Therapies.

  • Financings Roundup.  // BioWorld Today;1/28/2011, Vol. 22 Issue 19, p6 

    The article offers information on the public offering closed by Corcept Therapeutics Inc. for net proceeds of approximately 41.9 million U.S. dollars.

  • AFTERMARKET PERFORMANCE.  // Investment Dealers' Digest;1/24/2005, Vol. 71 Issue 3, p19 

    The article presents information on performance of recent initial public offerings (IPO), and recent stock offerings. Information has been presented in tabular form. Some of the issuers of IPOs are Jed Oil, Marchex, New River Pharmaceuticals Inc., Shanda Interactive Ent, Cogent,...

  • AFTERMARKET PERFORMANCE.  // Investment Dealers' Digest;12/6/2004, Vol. 70 Issue 47, p17 

    This article presents information about the aftermarket performance of the initial public offerings (IPO) of various companies in the U.S. The best performance was shown by issuer Shanda Interactive Entertainment Ltd. with an offer price of $11.00, percentage change of 261.818, amount to the...

  • IPOs IN THE U.S.  // Investment Dealers' Digest;10/20/2003, Vol. 69 Issue 40, p40 

    Provides information initial public offerings in the U.S. as of October 20, 2003. DigitalNet Holdings; Xcyte Therapies; GTX.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics